​

United Therapeutics Ownership | Who Owns United Therapeutics?

OverviewForecastRevenueFinancialsChartTranscripts

United Therapeutics Ownership Summary

United Therapeutics is owned by 97.33% institutional investors, 1.85% insiders, and 0.82% retail investors. Blackrock is the largest institutional shareholder, holding 11.64% of UTHR shares. iShares Core S&P Mid-Cap ETF is the top mutual fund, with 3.19% of its assets in United Therapeutics shares.

UTHR Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockUnited Therapeutics97.33%1.85%0.82%
SectorHealthcare Stocks 49.73%8.84%41.43%
IndustryBiotech Stocks 47.04%8.74%44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock5.47M11.64%$1.74B
Vanguard group4.42M9.40%$1.41B
Wellington management group llp3.29M6.99%$1.05B
Avoro capital advisors2.86M6.08%$910.70M
State street2.29M4.88%$730.83M
Renaissance2.17M4.63%$692.75M
Geode capital management1.05M2.23%$333.57M
Lsv asset management966.37K2.06%$307.84M
Morgan stanley806.99K1.72%$257.07M
Fmr763.62K1.62%$243.25M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Krensavage asset management118.21K17.29%$37.66M
Avoro capital advisors2.86M12.13%$910.70M
Palo alto investors lp266.91K9.85%$85.03M
Eagle health investments lp167.50K9.36%$53.36M
Eversept partners, lp235.35K5.13%$74.97M
Poplar forest capital110.62K4.92%$35.24M
Nitorum capital140.82K4.89%$44.86M
Parkman healthcare partners111.38K4.75%$35.48M
Summit street capital management36.43K4.24%$11.61M
Tri locum partners lp50.10K4.04%$15.96M

Top Buyers

HolderShares% AssetsChange
Lsv asset management966.37K0.67%436.85K
State street2.29M0.03%359.11K
Arrowstreet capital, limited partnership438.68K0.12%340.74K
Amundi472.99K0.06%307.96K
Morgan stanley806.99K0.02%270.78K

Top Sellers

HolderShares% AssetsChange
Citadel advisors---719.31K
Citigroup---309.30K
Vanguard group4.42M0.03%-264.13K
Fmr763.62K0.02%-253.99K
Janus henderson group410.01K0.07%-225.34K

New Positions

HolderShares% AssetsChangeValue
Lord, abbett155.53K0.16%155.53K$49.54M
National pension service82.30K0.03%82.30K$26.22M
Eventide asset management67.83K0.37%67.83K$21.61M
Corebridge financial56.10K0.10%56.10K$17.87M
Tri locum partners lp50.10K4.04%50.10K$15.96M

Sold Out

HolderChange
Financial synergies wealth advisors-1.00
Transamerica financial advisors-1.00
Financial gravity asset management-1.00
Tfo-tdc-2.00
Opal wealth advisors-2.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20246267.56%43,411,015-5.14%971.03%3080.65%22315.54%
Jun 30, 20245736.90%45,745,1772.56%971.08%30010.70%1929.09%
Mar 31, 20245360.19%44,601,6301.10%941.08%2710.37%1763.53%
Dec 31, 20235352.29%44,114,6921.35%931.09%2709.31%170-5.03%
Sep 30, 20235238.06%43,527,275-2.16%921.03%2474.22%17913.29%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
iShares Core S&P Mid-Cap ETF1.43M3.19%2.30K
Vanguard Total Stock Mkt Idx Inv1.40M3.14%-5.34K
Vanguard Small Cap Index1.12M2.50%2.20K
Vanguard Health Care Inv842.59K1.89%-
Vanguard Small Cap Value Index Inv753.88K1.69%-260.00
Vanguard Institutional Extnd Mkt Idx Tr661.20K1.48%-3.54K
Pacer US Cash Cows 100 ETF550.70K1.23%682.00
SPDR® S&P Biotech ETF547.15K1.23%-16.65K
FullerThaler Behavioral Sm-Cp Eq R6542.33K1.22%-
FullerThaler Behavioral Small-Cap Equity542.33K1.22%-

Recent Insider Transactions

DateNameRoleActivityValue
Dec 16, 2024BENKOWITZ MICHAEL PRESIDENT AND COOSell$282.39K
Dec 16, 2024BENKOWITZ MICHAEL PRESIDENT AND COOSell$492.91K
Dec 16, 2024BENKOWITZ MICHAEL PRESIDENT AND COOSell$36.33K
Dec 16, 2024BENKOWITZ MICHAEL PRESIDENT AND COOSell$36.50K
Dec 16, 2024BENKOWITZ MICHAEL PRESIDENT AND COOSell$558.54K

Insider Transactions Trends

DateBuySell
2024 Q4-129
2024 Q3-314
2024 Q2-357
2024 Q1-155
2023 Q4-26

UTHR Ownership FAQ

Who Owns United Therapeutics?

United Therapeutics shareholders are primarily institutional investors at 97.33%, followed by 1.85% insiders and 0.82% retail investors. The average institutional ownership in United Therapeutics's industry, Biotech Stocks , is 47.04%, which United Therapeutics exceeds.

Who owns the most shares of United Therapeutics?

United Therapeutics’s largest shareholders are Blackrock (5.47M shares, 11.64%), Vanguard group (4.42M shares, 9.40%), and Wellington management group llp (3.29M shares, 6.99%). Together, they hold 28.03% of United Therapeutics’s total shares outstanding.

Does Blackrock own United Therapeutics?

Yes, BlackRock owns 11.64% of United Therapeutics, totaling 5.47M shares as of Jun 2024. This represents 0.04% of BlackRock's total assets, with a market value of 1.74B$. In the last quarter, BlackRock decreased its holdings by -98.516K shares, a -1.77% change.

Who is United Therapeutics’s biggest shareholder by percentage of total assets invested?

Krensavage asset management is United Therapeutics’s biggest shareholder by percentage of total assets invested, with 17.29% of its assets in 118.21K United Therapeutics shares, valued at 37.66M$.

Who is the top mutual fund holder of United Therapeutics shares?

iShares Core S&P Mid-Cap ETF is the top mutual fund holder of United Therapeutics shares, with 3.19% of its total shares outstanding invested in 1.43M United Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools